Pharmaceuticals US

US Gout Treatment Market Analysis, 2024–2034

US Gout Treatment Market Industry Trends and Forecast to 2034: Segmented by (Drug Class, Type, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

US · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $1.33 Bn Estimated value
Estimate 2025 $1.41 Bn 34.6% of the global market
Projected 2034 $2.37 Bn 67.5% Adds $953.5 Mn over 9 forecast years
CAGR 2025–2034 5.9% Faster than 49% of 180 Pharmaceuticals markets here
Key players 5
  • US is 34.59% of the global market.
  • In North America, the largest is US (this report) at $1.41 Bn.
  • Fastest growing: Canada at 7.7% a year.
  • US ranks 1st of 2 by size in North America.

Market size projection

US

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$953.5 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Gout Treatment Market market size by year, US
YearMarket sizeChange that yearSince 2025
2024 (estimate) $1.33 Bn — —
2025 (base) $1.41 Bn +$78.7 Mn —
2026 (forecast) $1.50 Bn +$83.3 Mn +5.9%
2027 (forecast) $1.58 Bn +$88.2 Mn +12.1%
2028 (forecast) $1.68 Bn +$93.4 Mn +18.8%
2029 (forecast) $1.78 Bn +$99.0 Mn +25.8%
2030 (forecast) $1.88 Bn +$104.8 Mn +33.2%
2031 (forecast) $1.99 Bn +$111.0 Mn +41.1%
2032 (forecast) $2.11 Bn +$117.5 Mn +49.4%
2033 (forecast) $2.23 Bn +$124.5 Mn +58.2%
2034 (forecast) $2.37 Bn +$131.8 Mn +67.5%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $4.08 Bn
  2. North America $2.10 Bn
  3. US (this report) $1.41 Bn
  4. APAC $889.8 Mn
  5. Europe $770.6 Mn
  6. Canada $372.3 Mn
  7. China $292.5 Mn
  8. Japan $233.3 Mn
  9. Middle East $186.7 Mn
  10. Latin America $163.1 Mn
  11. Germany $141.7 Mn
  12. France $119.0 Mn
  13. UK $117.2 Mn
  14. Brazil $119.5 Mn
  15. Italy $102.5 Mn
  16. Ecuador $86.4 Mn
  17. Spain $80.8 Mn
  18. India $83.8 Mn
  19. Africa $69.3 Mn
  20. Saudi Arabia $62.4 Mn
  21. Mexico $55.0 Mn
  22. Australia $46.1 Mn
  23. Russia $44.0 Mn
  24. New Zealand $43.8 Mn
  25. South Africa $26.4 Mn
  26. UAE $20.8 Mn
  27. Egypt $10.6 Mn
  28. Philippines $9.1 Mn
  29. Hong Kong $7.3 Mn
  30. Malaysia $7.3 Mn
  31. Singapore $5.6 Mn
  32. Thailand $5.2 Mn
  33. Kenya $3.0 Mn

The US Gout Treatment Market Analysis Executive Summary

Gout treatments lower uric acid and control painful flares caused by crystals in the joints.

Key segments of the gout Treatment market include drug class (Xanthine Oxidase Inhibitors, Uricosurics and Colchicine) and type (Acute Gout and Chronic Gout).

US Gout Treatment Market Dynamics

Market Growth Drivers

Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the gout Treatment market. Wider insurance coverage and more doctors trained in obesity care are adding to demand.

Opportunity

Oral formulations, combination therapies and use in heart, kidney and liver disease open new growth paths for the gout Treatment market, especially in fast-growing emerging economies.

Market Restraints

High treatment prices, limited reimbursement, supply shortages and side effects that lead some patients to stop treatment hold back the gout Treatment market. Long-term safety data and lifestyle support are still needed for many patients.

Competitive Landscape for Gout Treatment Market in US

The gout Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Gout Treatment Market in US

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for gout Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in US.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Gout Treatment right now, from free public sources.

Clinical trials

17 active trials in the US

Recruiting, about to start, or running now.

Top trial sponsors (worldwide)

  1. Crystalys Therapeutics 3 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Shanton Pharma 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Latest research 135 papers since 2021 (worldwide)

  1. Telemedicine in Rheumatology in the United States: A Scoping Review of Modalities, Outcomes, and Costs in Support of a Hybrid Model of Care. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2026
  2. Molecular modelling study on Piper betle phytocompounds to discover the potential active moiety responsible for xanthine oxidase inhibition in avian gout. British poultry science, 2026
  3. Colchicine-related effects on gene and protein expression in gout. Current opinion in rheumatology, 2026
  4. Modulatory effects of methyl gallate on the inflammatory response in gout arthritis via P2X7 receptor. Anais da Academia Brasileira de Ciencias, 2026
  5. A self-management app in a digital treat-to-target gout-care approach: the ReMonit Gout feasibility study. Scandinavian journal of rheumatology, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Gout Treatment in context

The US compared

  • Health spending per person: 13,473 US$ per person (2023). World: 1,317 US$ per person (2023).[1]
  • Doctors: 3.68 per 1,000 people (2022). World: 1.86 per 1,000 people (2022).[2]
  • People aged 65 and over: 18.4% of people (2025). World: 10.4% of people (2025).[3]

Questions, answered with public data

How many clinical trials on Gout Treatment are running in the US?
17 studies are recruiting, active or about to start in the US.[4]
How much research is published on Gout Treatment?
PubMed lists 135 papers added since January 2021 that match this market, worldwide.[5]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.

[4] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 12 Nov 2026.

[5] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Gout Treatment in US? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Cannabis-Based Medicines: Science and RegulationThe FDA has approved one cannabis-derived medicine, Epidiolex, for rare epilepsies, and three synthetic…
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in US

See all
Same topic, other categories

Related on pain

See the topic